Michael Grimm

5.6k total citations
117 papers, 4.3k citations indexed

About

Michael Grimm is a scholar working on Surgery, Immunology and Oncology. According to data from OpenAlex, Michael Grimm has authored 117 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 25 papers in Immunology and 23 papers in Oncology. Recurrent topics in Michael Grimm's work include Inflammatory Bowel Disease (16 papers), Salmonella and Campylobacter epidemiology (13 papers) and Immune Cell Function and Interaction (12 papers). Michael Grimm is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Salmonella and Campylobacter epidemiology (13 papers) and Immune Cell Function and Interaction (12 papers). Michael Grimm collaborates with scholars based in Australia, United States and Austria. Michael Grimm's co-authors include Joost J. Oppenheim, O. M. Zack Howard, Paul Pavli, William F. Doe, W F Doe, Li Zhang, Stephen M. Riordan, Miriam R. Anver, William J. Murphy and Hynda K. Kleinman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Michael Grimm

113 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Grimm Australia 37 1.4k 990 869 693 551 117 4.3k
Salomon Amar United States 50 2.5k 1.8× 2.7k 2.7× 723 0.8× 944 1.4× 462 0.8× 137 9.3k
Alan D. Irvine Ireland 58 2.2k 1.6× 2.3k 2.3× 439 0.5× 804 1.2× 853 1.5× 298 17.2k
Hiromi Nakamura Japan 40 729 0.5× 1.2k 1.3× 1.1k 1.3× 1.7k 2.5× 190 0.3× 215 5.9k
Bruce Horwitz United States 36 2.1k 1.5× 1.1k 1.2× 1.1k 1.3× 621 0.9× 746 1.4× 79 4.2k
Matthias Zilbauer United Kingdom 30 528 0.4× 1.1k 1.1× 362 0.4× 502 0.7× 604 1.1× 74 2.7k
Denis F. Kinane United States 65 2.1k 1.5× 1.9k 2.0× 468 0.5× 366 0.5× 399 0.7× 186 12.7k
Antonios O. Aliprantis United States 34 2.0k 1.4× 2.6k 2.7× 1.1k 1.2× 449 0.6× 441 0.8× 60 6.3k
Shisan Bao Australia 44 1.9k 1.4× 1.7k 1.7× 662 0.8× 926 1.3× 463 0.8× 224 6.6k
Tilo Biedermann Germany 56 3.3k 2.4× 1.3k 1.4× 682 0.8× 844 1.2× 296 0.5× 442 11.0k
Jing Ouyang China 35 1.9k 1.3× 1.6k 1.6× 1.8k 2.1× 279 0.4× 299 0.5× 124 5.0k

Countries citing papers authored by Michael Grimm

Since Specialization
Citations

This map shows the geographic impact of Michael Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Grimm more than expected).

Fields of papers citing papers by Michael Grimm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Grimm. The network helps show where Michael Grimm may publish in the future.

Co-authorship network of co-authors of Michael Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Grimm. A scholar is included among the top collaborators of Michael Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Grimm. Michael Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holfeld, Johannes, Felix Nägele, Leo Pölzl, et al.. (2024). Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial. European Heart Journal. 45(29). 2634–2643. 5 indexed citations
2.
Goldstein, Daniel A., Dionisia Quiroga, Mahmoud Kassem, et al.. (2023). The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Oncology and Therapy. 11(3). 361–374. 1 indexed citations
3.
4.
Gollmann‐Tepeköylü, Can, Felix Nägele, Michael Graber, et al.. (2022). Different calcification patterns of tricuspid and bicuspid aortic valves and their clinical impact. Interactive Cardiovascular and Thoracic Surgery. 35(6). 4 indexed citations
5.
Grimm, Michael, et al.. (2022). Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Current Treatment Options in Oncology. 23(1). 29–42. 43 indexed citations
6.
Vollmer‐Conna, Uté, et al.. (2021). A Review of Inflammatory Bowel Disease: A Model of Microbial, Immune and Neuropsychological Integration. Public health reviews. 42. 1603990–1603990. 87 indexed citations
7.
Liu, Fang, Rena Ma, Chin Yen Tay, et al.. (2018). Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn’s disease. Emerging Microbes & Infections. 7(1). 1–14. 28 indexed citations
8.
Hoefer, Judith, Hanno Ulmer, Juliane Kilo, et al.. (2017). Antithrombin III is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support. Journal of Thoracic and Cardiovascular Surgery. 153(6). 1374–1382. 19 indexed citations
9.
Leach, Steven T., et al.. (2017). The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune System. Frontiers in Immunology. 8. 417–417. 122 indexed citations
10.
Mazumder, Sandip & Michael Grimm. (2011). Numerical Investigation of Radiation Effects in Monolithic Catalytic Combustion Reactors. International Journal of Chemical Reactor Engineering. 9(1). 4 indexed citations
11.
12.
Müller, Tobias, Thorsten Dürk, Britta Blumenthal, et al.. (2010). Iloprost has potent anti‐inflammatory properties on human monocyte‐derived dendritic cells. Clinical & Experimental Allergy. 40(8). 1214–1221. 21 indexed citations
13.
Cheluvappa, Rajkumar, Gerene M. Denning, Gee W. Lau, et al.. (2010). Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells. International Journal of Infectious Diseases. 14(10). e857–e867. 30 indexed citations
14.
Cheluvappa, Rajkumar, Gerene M. Denning, Gee W. Lau, et al.. (2009). Pseudomonas aeruginosa and the hyperlipidaemia of sepsis. Pathology. 41(7). 615–621. 11 indexed citations
15.
Gibson, Kathryn, Patrick M. Boyle, Deborah Black, et al.. (2008). Enhancing Evaluation in an Undergraduate Medical Education Program. Academic Medicine. 83(8). 787–793. 37 indexed citations
16.
Huber, Kurt, H. Baumgartner, Harald Darius, et al.. (2006). Der Einsatz von Clopidogrel bei Patienten mit akuten Koronarsyndromen, nach perkutaner koronarer Intervention und Stentimplantation. Journal für Kardiologie (Krause & Pachernegg GmbH). 13(5). 168–174. 1 indexed citations
17.
Grimm, Michael, Susan J. Connor, Yingying Le, et al.. (2003). Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans -Deactivating Chemokine Receptors. The Journal of Immunology. 171(10). 4990–4994. 37 indexed citations
18.
Biragyn, Arya, et al.. (1999). Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nature Biotechnology. 17(3). 253–258. 240 indexed citations
19.
20.
Grimm, Michael, et al.. (1996). Interleukin 8: cells of origin in inflammatory bowel disease.. Gut. 38(1). 90–98. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salomon Amar Breakdown of academic impact, for papers by Alan D. Irvine Breakdown of academic impact, for papers by Hiromi Nakamura Breakdown of academic impact, for papers by Bruce Horwitz Breakdown of academic impact, for papers by Matthias Zilbauer Breakdown of academic impact, for papers by Denis F. Kinane Breakdown of academic impact, for papers by Antonios O. Aliprantis Breakdown of academic impact, for papers by Shisan Bao Breakdown of academic impact, for papers by Tilo Biedermann Breakdown of academic impact, for papers by Jing Ouyang
Rankless by CCL
2026